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Normally functioning marrow stem cells have a high proliferative capacity, but can be 
serially transplanted only three to five times before that capacity is severely diminished 
(1-4).  This loss may demonstrate the natural limit of stem cell proliferative capacity, but 
it may also result from damage caused by the unnatural  procedure of transplantation. 
The proliferative capacity of nontransplanted stem cells is tested by repeatedly irradiat- 
ing the animal containing them,  and thus  forcing the cells to regenerate repeatedly. 
Under these conditions,  marrow stem cells start with a high capacity for regeneration 
which eventually diminishes with repeated irradiation, and the treated animals die (5). 
This  may be  caused  by stem  cell  exhaustion  or  by other  cumulative  effects  of the 
irradiation treatments. 
The  ambiguities  caused  by  damage  from  the  process  of transplantation  or  from 
treatment to destroy stem cells are removed by comparing the proliferative capacities of 
stem cells from old and young individuals. This experiment also answers a question that 
is relevant to the health care of elderly individuals: is a significant amount of stem cell 
proliferative capacity used up during a lifetime of normal functioning? 
Unfortunately, results in this area are conflicting. Some investigators find defects in 
stem cells from old individuals (6-8), whereas others report no difference in functional 
abilities  of old  and  young  stem  cells  (9-11).  Recently,  Albright  and  Makinodan  (8) 
suggested  that  old  stem  cells  cannot  multiply  as  rapidly  as  can  young  stem  cells 
immediately after transplantation,  although they are able to multiply and differentiate 
into normally functional immunohemopoietic cells if given adequate time. This sugges- 
tion was supported by findings that the macroscopic spleen colonies produced by old stem 
cells contained fewer cells.  It conflicted with the recent report by Ogden and Micklem 
(11) that young marrow cells identified by chromosome markers and mixed with equal 
numbers of old marrow cells showed no competitive advantage in irradiated recipients. 
Only two separate old vs. young pairs were used; the young having the advantage in one 
case, and the old in the other. 
The  system of mixing old  and  young  marrow cells  and  determining  which 
better repopulates  irradiated  recipients  compares stem cell proliferative rates 
immediately after transplantation.  If young stem cells are capable of multiply- 
ing more rapidly than old cells immediately after transplantation,  as suggested 
by  Albright  and  Makinodan  (8),  the  young  cells  would  have  a  competitive 
advantage  in  repopulating  irradiated  recipients.  We  therefore  compared  the 
repopulating ability in irradiated recipients of many different young-old pairs, 
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and we also measured the rates of spleen colony growth, using stern cells from 
young and old donors. In both cases we also studied previously transplanted old 
and young marrow stem cell lines to directly compare the effects of aging and 
transplantation. 
Materials  and  Methods 
Mice.  CBA/H-T6J  mice  carrying  two  translocated  T6  chromosomes  (2T6),  (CBA/H-T6J  x 
CBA/CaJ)F~ mice carrying one translocated T6 chromosome  (1T6),  compatible CBA/CaJ  (0T6) 
mice, (C57BL/6J  x  CBA/H-T6J)F~  ffi B6CBAT6F~ mice, and (C57BL/6J x  CBA/CaJ)F~ W~/W  ~" = 
B6CBAF~-W~/W  ~' mice were bred and maintained at The Jackson Laboratory, which is fully ac- 
credited by The American Association for Accreditation of Laboratory Animal Care.  Old mice 
ranged from 25 to 33 mo of age while young ones were 3-8 mo old.  Care was taken in autopsy 
procedures to use only healthy old mice as previously described (10). The evening before the cells 
were injected,  irradiated recipients received 750-850 R  of total body X-irradiation as described 
previously (10). 
Rates of Colony Growth.  Macroscopic spleen colonies (12) were counted on unfixed spleens of 
lethally irradiated histocompatible mice 9 days after irradiation and intravenous infection of 1.0 
x  105 marrow cells. Then spleen cells were suspended in 2.0 ml of Ks 74, a  buffered salt solution 
(13),  after dispersion with a  glass tissue homogenizer. The homogenate was filtered through 100 
mesh nylon cloth, removing small chunks of gelatinous stroma; aliquots were diluted and counted 
on a  Coulter model ZBI electronic cell counter (Coulter Electronics Inc., Hialeah, Fla.). 
Comparative Repopulating Ability.  Marrow cells were removed by rinsing both femurs and 
tibias of each donor with chilled CMRL-1066 media ~Grand Island Biological Co.,  Grand Island, 
N. Y.) or Ks 74 (13) driven into one end of the bone through a 23-gauge disposable needle. Chunks 
were broken up by  dispersing them through a  disposable plastic  1-ml syringe with no needle 
attached  and  with its outlet pressed gently against the bottom of a  4oml  sterile plastic tube. 
Marrow cells were stored on ice, counted as described above for spleen cells, and injected within 
1-3 h  after removal.  Marrow cells from each 2T6 donor were mixed with equal numbers of cells 
from the same young 1T6 donor in each experiment, and they were injected intravenously into 
lethally irradiated 0T6 recipients. Amounts were adjusted to contain 3 ×  106 marrow cells of each 
chromosomal  type.  This  is  a  new  procedure  making  it  possible  to  compare  the  repopulating 
abilities of marrow cells from several 2T6 donors at once. For example, in four experiments, the 
2T6 donors included not only a young and an old individual, but also two irradiated 0T6 recipients 
previously populated with a young and with an old 2T6 stem cell line, respectively. Cells from all 
four 2T6 donors were mixed with cells from the same young 1T6 donor. Thus, the percentage of 
2T6 cells in each case gave the relative proliferative ability of marrow stem cells from each 2T6 
donor immediately  after transplantation by measuring how well they competed with the  1T6 
cells. 
Recipients of the mixtures of 2T6 and 1T6 marrow cells were used 3-16 mo after irradiation and 
marrow transplantation. Their spleens were removed under anesthesia, and the numbers of T6 
chromosomes in mitotic spleen cells were determined after stimulation in vitro with phytohemag- 
glutinin  (PHA)  by  methods  previously  described  in  detail  (10).  Erythrepoietic  mitoses  were 
stimulated by removing 25-35% of the recipient's blood; marrow cells were removed for study 3 
days  later.  Cells  in  mitosis  were  fixed  in  metaphase  for  determination  of  numbers  of  T6 
chromosomes  using  Ford's  methods  (14).  Only  those  cells  with  all  40  chromosomes  clearly 
distinguishable were scored. 
Results 
There were no differences between young and old donors in colony-forming 
unit  (CFU) numbers  (A),  numbers  of cells per spleen  (B),  growth potentials 
(A x  B), or cells per CFU (B/A) in mice of the two genotypes tested (Table I) at 
the initial  transplantation.  With CBA mice at the third  transplantation,  the 
growth potential  of colonies from old donors was 2.4 times that of the young; 
with  B6CBAF1  mice  at  the  second  and  third  transplantations,  the  growth 
potential of colonies from young donors was 1.5-1.6 times that of the old (Table 
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TABLE  I 
Macroscopic  Colony Growth in  Irradiated  Recipient  Spleens 
Donor  Recipient splenic values (mean  ±  SE) 
(A) Number of colo- 
Age  Transplant  niee  (B) Cell number  A  x  B  B/A 
CBA  mice* 
Old 
Young 
Old 
Young 
Old 
Young 
B6CBAF~  mice~ 
Old 
Young 
Old 
Young 
Old 
Young 
1  6.6 ±  0.4  13.2 -+ 7.1  96 ± 58  1.8 ±  0.9 
I  7.0 ± 0.7  13.1 ± 3.8  99 ±  36  1.8 ± 0.4 
2  5.9  -+ 0.3  5.4  ±  0.2  37  ±  3  0.8  ±  0.1 
2  6.2  -+  0.7  6.1  -+ 2.1  41  ±  18  1.0  ±  0.2 
3  6.2 -+ 1.0  5.5 ±  1,7  43 ±  15  1.0 ± 0.I 
3  4.0 ±  1.5  3.5 ±  1.6  18 -.+  9  0.8 ± 0.I 
1  8.1  ±  0.9  25.0 ±  5.9  224  ±  60  2.9  ±  0.5 
1  7.5  ±  0.5  27.8 ±  4.8  220  ±  54  3.6  ±  0,4 
2  6.4  ±  0.6  14.2 ±  1.6  88  ±  5  2.4  ±  0.5 
2  7.4  ±  0.6  19.0  ±  1.3  142  ±  17  2.0  ±  0.3 
3  4.7  10.0  47  2.1 
3  5.0  14.0  70  2.8 
Each mean ±  SE is for 3 or 4 donors with CBA mice or 5 donors with B6CBAFt mice in three experiments.  Values for individual 
donors were the means of  5 or 6 irradiated recipients of 1.0 x  I0  ~ marrow cells  each (i.v.)  per donor. (A) stands for number of 
colonies,  and (B) for  cell  number (  x 10  s)  per  spleen given aRer subtracting valmm for  identical irradiated recipiente  injected  with 
suspending media containing no cells  for CBA  recipients, or containing 1.0 x 10  B  W=/W"  cells  for B6CBAFI  recipients. 
(A) and (B) are multiplied (A x B) to give the growth potential, and divided (B/A) to give the number of  cells  per colony. 
* Marrow stem cell  lines  from CBA/HT6  donors were carried in lethally  irradiated CBA/CaJ recipients  for  transplants 2 and 3, 
using 4-10 ×  106 marrow cells  per recipient  and 4-12 mo between serial  transplantetious. Age in months given as mean - SE 
(n):  for old donors, 25.7 ±  0.5 (7);  for young donors, 5.0 ±  0.6 (8). 
Marrow stem cell  lines from B6CBATTF~  donors were carried in unirradiated BSCBAFz  -  Wz/W  "  recipients for transplant 2 
using 10 x 10  ~ marrow cells  per recipient  with 11-13 mo between serial  transplantations. The same number of  cells  with 4 rno 
was used for  transplant 3. Age in months is  given as  mean ± SE (n):  for  old  donors, 29.0 ± 0.8 (8);  for  young donors, 7.4 ± 0,3 (8). 
Much  larger differences were evident with increasing numbers  of serial 
transplantations than with increasing age. The number of cells  per spleen, 
growth potentials,  and number of  cells  per  colony dropped to  40-70% when stem 
cell  lines  serially  transplanted once (transplant 2, Table I)  were compared with 
those never transplanted before (transplant 1,  Table I). Colony numbers stayed 
constant between transplant 1 and 2, but generally declined in transplant 3, 
causing declines  in  the number of  cells  per spleen and in growth potentials;  the 
number of cells  per colony remained constant between transplants 2 and 3 
(Table I). 
The percentage of  2T6 cells  which populated irradiated  recipients  in competi- 
tion with 1T6 cells  diminished to a much greater extent in donors whose cells 
were previously transplanted once (transplant 2) than in old donors (Table II). 
When mitoses were stimulated by bleeding, there was no difference  between 
cells  from old and young 2T6 donors (transplant i, Table II),  but there was a 
two- to  fourfold  decline  in  the  ability  to  compote with cells  from the 1T6 donor in 
stem cell  lines  that had been transplanted once previously (Transpl. 2, Table 
If).  When mitoses were stimulated by PHA  in  vitro,  stem cell  lines  from old  2T6 
donors showed a slight  defect,  producing about 70% of  the 2T6 cells  of  young 2T6 
donors. However, stem cell  lines  of  both age groups serially  transplanted once 
competed 4- to 10-fold  less  well than those not previously transplanted (Table 
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TABLE  II 
Percentage of  2T6 Cells in Lethally Irradiated Recipients of  2T6 
and 1T6 Marrow 
2T6 Donors  2T6 Mitoses after 
Age  Transplant  Bleeding  PHA 
Old  1  55 ±  5 (23)  33 ±  4 (16)* 
Young  1  58 -+ 4 (21)  47 ±  4 (18) 
Old  2  27 ±  8 (6)$  9 ±  3 (5)$ 
Young  2  13 ±  4 (5)$  4 ±  1 (4)$ 
Results are given as mean  ±  SE (number of recipients scored).  A mean of 45 (range 20-64) 
mitoses was scored for each recipient.  Old or young 2T6 (CBA/HT6J) marrow was mixed with 
equal  amounts  (3  x  106 cells each)  of young  1T6 (CBA/HT6J  x  CBAJCaJ)  marrow  and 
transplanted  into lethally irradiated young  0T6 (CBA/CaJ) recipients in transplant  1. In 
transplant 2, marrow from the 2T6 donors had been previously injected i.v. (4-10 ×  106 cells) 
in 0T6 recipients; these recipients were held for 4-6 mo before they were used as donors. Age 
in months is given as mean ± SE (n): for old 2T6 donors, 28.3 ± 0.6 (16); for young 2T6 donors, 
5.4 ±  0.3 (15); for young 1T6 competitors,  5.4 ±  0.3 (7). 
* Significantly lower 0.01 < P  <  0.06 by Student-Neuman-Keuls multiple range test. 
Significantly lower P  <  0.01 by Student-Neuman-Keul8 multiple range test. 
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Discussion 
We found no loss in growth potential  of colony-forming cells from old mice 
(Table I), directly contradicting Albright and Makinodan (8) who found a 2.5- to 
5-fold loss using mice of three different strains. There are three possible reasons 
for  this  contradiction.  First,  we  calculated  growth  potential  by  a  different 
method,  multiplying  total colony numbers per spleen by the total number of 
cells in the spleen which resulted from the injected marrow cells (above back- 
ground).  We used this  procedure because essentially all proliferating  cells in 
such a  spleen are part of the colony and are of donor origin  (8).  Albright  and 
Makinodan  (8)  calculated  growth  potential  by multiplying  the  total  colony 
number  per  spleen by the  number  of cells  in  the  largest  colony.  This  could 
give falsely high  growth  potentials  for young marrow  cells if they produced 
colonies with  greater  variability  in  size than  were produced  by old marrow 
cells.  Second, the old donors we used may have been more free of factors sup- 
pressing colony growth because of differences either in general  animal health 
or in autopsy procedures.  Third,  we used different strains  of mice which may 
differ in the effects of age on stem cells.  Our results  are consistent with the 
finding of Lajtha and Schofield (15) that the growth rates of colonies from young 
or old donors do not differ significantly during the first 11 days after grafting, 
even  though  we  measured  total  numbers  of cells  and  they  measured  total 
numbers of colony-forming cells in the recipient spleens. 
Our findings that old and young hemopoietic stem cells have equally potent 
proliferative capacities immediately after transplantation  confirm and extend 
findings  reported  by  Ogden  and  Micklem  (11).  These  investigators  studied 
recipients  from  only  2  pairs  of old  and  young  donors  (11);  in  contrast,  we 
compared  15  pairs  of  old  vs.  young  donors  from  the  CBA/H-T6  and  the 
B6CBAT6F1 genotypes in Table I,  and  15 pairs  from the CBA/H-T6 strain  in 
Table II. We maximized the number of old donors and young controls because 
old individuals are highly variable  (10),  and we wanted to avoid being misled 
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The  evidence  that  stem  cells  from  old  mice  were  slightly  defective  in 
producing PHA-responsive cells (Table II) confirms results previously reported 
(10). This defect apparently resulted from stem cell residence in the old animal 
rather than being intrinsic to the stem cells, since it was not present in old stem 
cells in transplant 2 (Table II). 
Although old and young stem cell lines gave similar results, the techniques 
we used were sensitive enough to detect large defects in stem cell lines after a 
single serial transplantation, even though we transplanted high numbers of 
marrow cells (4-10  ×  106) and waited a  lengthy interval (4-12  mo) before the 
second transplantation. Numbers of spleen cells but not numbers of colonies 
declined 1.5- to 2.5-fold after one serial transplantation (Table I). The ability to 
populate irradiated recipients declined even more strikingly, 2- to 4-fold in cells 
stimulated by bleeding, and 4- to 10-fold in cells stimulated by PHA (Table II). 
When such high marrow cell numbers and long transplantation intervals are 
used,  other techniques  do not  detect striking changes  until  after 2-4  serial 
transplantations (2-4,  9,  11). 
These results suggest that even one transplant is a much more severe stress 
for marrow stem cells than is normal functioning during a lifetime. The stress 
may result from damage by the transplantation process, dilution of a nonprolif- 
erating reserve of the earliest stem cells, exhaustion of proliferative capacity, 
or some combination of these.  Little or none of the proliferative capacity in 
immunohemopoietic stem cell lines of mouse marrow appears to be used up by 
normal functioning throughout the adult lifespan. 
Summary 
Marrow stem cell lines from old donors and those from young controls gave 
equally rapid  rates  of colony growth on spleens of irradiated mice.  Old  and 
young  stem  cell  lines  competed  equally  well  with  chromosomally marked 
marrow  stem  cells  from  a  young  donor  in  producing  cell  types  that  are 
stimulated by bleeding; old cells competed 70% as well as young in producing 
cell  types stimulated by phytohemagglutinin (PHA)  in  vitro.  After a  single 
serial transplantation, the rates of colony growth declined 1.5- to 2.5-fold,  and 
the ability to compete declined 2- to 4-fold for bleeding-stimulated and 4- to 10- 
fold for PHA-stimulated cells. Thus, immediate stem cell proliferative capacities 
decline  much more  after one  serial transplantation than after a  lifetime of 
normal function. 
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